Your cart is empty.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
- Shop
- Blog
-
About
About Tecan
Investors
Press Center
People
Publications
- Support
- Contact
- Life Sciences
- Diagnostics
- Partnering
- Language
Tecan Journal
Selected category: HMGB1 ELISA
Back to overview
Finding a clinical future for HMGB1?
Extracellular HMGB1 has been implicated in a wide range of conditions, from trauma and sepsis to epilepsy and lupus. As a result, this almost ubiquitous biomolecule is garnering increasing interest as a potential target for new therapeutics. In a recent review paper, Prof Ulf Andersson et al. summarized the latest advances in our understanding of the release, receptor interactions and functional consequences of extracellular HMGB1.